PMN · CIK 0001374339 · operating
ProMIS Neurosciences Inc. (PMN) is a pharmaceutical preparations company incorporated in Canada (Federal Level), listed on the Nasdaq. With a market capitalization of $43 million, ProMIS Neurosciences Inc. is a micro-cap company. The stock currently trades at $22.95, down 2.38% today, with a 52-week range of $6.27–$39.75.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $0.11 | $0.11 | +110.3% | |
| 2023 | $-1.07 | $-1.07 | +55.6% | |
| 2022 | $-2.41 | $-2.41 | — |